Long-term impact of recombinant human erythropoietin on transfusion support in patients with chronic renal failure
By: M. A. Popovsky and B.J. Ransil
Paid access
|Nov 2020❗ Available for purchase in USD only.
❗ Available for purchase in USD only.
Authors
M. A. Popovsky
Chief Medical Officer, Acting Principal Officer, American Red Cross Blood Services, New England Region, Assistant Professor of Pa thology, Harvard Medical School and Beth Israel Hospital, Boston, United States
B.J. Ransil
Dana Research Institute and Harvard-Thorndike Laboratory of Beth Israel Hospital, Department of Medicine, Beth Israel Hospital and Harvard Medical School, Boston, United States
DOI: https://doi.org/10.21307/immunohematology-2019-736 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 1 - 3
Published on: Nov 10, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2020 M. A. Popovsky, B.J. Ransil, published by American National Red Cross
This work is licensed under the Creative Commons License.